What is the recommended treatment for a patient with contact dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Contact Dermatitis

The cornerstone of contact dermatitis treatment is complete avoidance of the causative allergen or irritant combined with mid-to-high potency topical corticosteroids (such as triamcinolone 0.1% or clobetasol 0.05% twice daily) and aggressive emollient therapy. 1

Immediate First-Line Management

Allergen/Irritant Identification and Avoidance

  • Replace all soaps and detergents with emollients immediately, even if they are not the identified cause, as these are universal irritants that perpetuate inflammation 1
  • Obtain a detailed history including initial location of symptoms, spread pattern, relationship to specific products or activities, and occupational/recreational exposures 1
  • For persistent cases (>2 weeks despite treatment), refer for patch testing with an extended standard series of allergens to identify specific causative agents 1, 2
  • Pattern and morphology alone are unreliable in distinguishing between irritant, allergic, or endogenous dermatitis, making patch testing essential when diagnosis remains uncertain 1

Topical Corticosteroid Therapy

For localized disease:

  • Apply mid-potency topical corticosteroid (triamcinolone 0.1%) twice daily for 1-2 weeks for mild-to-moderate cases 3, 4
  • For more severe localized disease, escalate to high-potency corticosteroid (clobetasol 0.05%) twice daily for up to 2 weeks, which achieves clear or almost clear skin in 67.2% of severe cases 2
  • Do not use high-potency topical steroids on the face, groin, axillae, or genital regions due to increased absorption and risk of skin atrophy 3

For extensive disease (>20% body surface area):

  • Systemic corticosteroid therapy is often required and offers relief within 12-24 hours 4
  • For severe rhus dermatitis, taper oral prednisone over 2-3 weeks to prevent rebound dermatitis from rapid discontinuation 4

Important distinction for irritant vs. allergic contact dermatitis:

  • Topical steroids are the primary treatment for allergic contact dermatitis and should be applied promptly 3
  • For irritant contact dermatitis, use topical steroids only after conservative measures fail, as prolonged use may damage the skin barrier 1, 3

Aggressive Emollient Therapy

  • Apply moisturizers liberally and frequently—use two fingertip units to hands after each washing 1, 2
  • Use moisturizers packaged in tubes rather than jars to prevent contamination 1
  • Implement the "soak and smear" technique: soak affected area in plain water for 20 minutes, then immediately apply moisturizer to damp skin nightly for up to 2 weeks 1, 2, 3
  • For trunk involvement, apply approximately 100g of moisturizer per 2 weeks 1

Protective Measures

Glove Selection and Use

  • For household tasks, use rubber or PVC gloves with cotton liners 1
  • For latex allergy, use accelerator-free neoprene or nitrile gloves 1
  • In occupational settings, select gloves based on specific chemical exposures and check Material Safety Data Sheets for permeation times—no glove is completely impermeable 1
  • Remove gloves regularly to prevent sweat accumulation, which can aggravate dermatitis 1
  • Apply moisturizer before wearing gloves 1

Barrier Creams

  • Do not over-rely on barrier creams alone—they have questionable clinical value and may create false security, reducing implementation of appropriate preventive measures 1
  • After-work creams have demonstrated benefit in reducing irritant contact dermatitis incidence and should be readily available in workplace settings 1

Second-Line Therapies for Refractory Cases

When first-line treatment fails after 2 weeks:

Topical Calcineurin Inhibitors

  • Consider topical tacrolimus 0.1% or pimecrolimus 1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage 1, 2, 3
  • Tacrolimus 0.1% is particularly useful for facial or thin-skinned areas where steroid atrophy is a concern 2
  • Pimecrolimus 1% is FDA-approved for atopic dermatitis in patients 2 years and older, with 35% achieving clear or almost clear skin at 6 weeks 5
  • Important safety consideration: The long-term safety is not fully established; use only on areas with active dermatitis, not continuously for prolonged periods 5

Phototherapy

  • PUVA (psoralen plus UVA) is an established second-line treatment for chronic hand eczema resistant to topical steroids, supported by prospective clinical trials 1, 2

Systemic Immunosuppressants

  • For severe chronic hand eczema, alitretinoin is specifically recommended (strong recommendation) 1
  • Consider azathioprine or ciclosporin for steroid-resistant chronic contact dermatitis 1, 2
  • Methotrexate and mycophenolate mofetil are additional options for refractory cases 1, 6

Special Considerations

Post-Surgical Contact Dermatitis

  • Immediately discontinue all topical antibiotics, especially neomycin and bacitracin 2
  • Switch to plain white petrolatum for wound care 2
  • Apply mid-to-high potency topical corticosteroid (triamcinolone 0.1%) two to three times daily 2

Occupational Contact Dermatitis

  • Arrange workplace visits to identify hidden allergens, assess procedures causing accidental exposure, and review Material Safety Data Sheets 1
  • Implement comprehensive educational programs, which demonstrate improvements in established hand dermatitis and prevention of new cases 1
  • Prognosis is poor: only 25% achieve complete healing over 10 years, 50% have intermittent symptoms, and 25% have permanent symptoms 1
  • Changing occupation does not improve prognosis in 40% of cases 1

Monitoring for Complications

  • Monitor for signs of topical steroid allergy—paradoxically, worsening dermatitis despite treatment warrants patch testing to corticosteroid allergens 1, 3
  • Watch for skin atrophy, telangiectasia, perioral dermatitis, and red face syndrome with prolonged facial corticosteroid use 1
  • Patients who develop lymphadenopathy should have etiology investigated; discontinue treatment if no clear etiology or if acute infectious mononucleosis is present 1

Critical Pitfalls to Avoid

  • Do not wash hands with dish detergent or other known irritants 1
  • Avoid very hot or very cold water for hand washing 1
  • Do not use disinfectant wipes to clean hands 1
  • Avoid products containing topical antibiotics without indication 1
  • Do not apply prolonged occlusion without underlying moisturizer application 1
  • Do not recommend exclusion diets—no good-quality studies support their use in contact dermatitis management 1

When to Reassess and Escalate

  • Reassess patients after 2 weeks of appropriate topical corticosteroid treatment 2, 3
  • If no improvement after 2 weeks, perform patch testing to identify clinically relevant allergens 1, 3, 4
  • For persistent dermatitis despite high-potency steroids and allergen avoidance, refer for dermatology consultation and consider second-line systemic therapies 1, 2

References

Guideline

Contact Dermatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Post-Surgical Contact Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Topical Steroid Treatment for Contact Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of contact dermatitis.

American family physician, 2010

Research

Medical management of contact dermatitis.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.